Independent consulting that equips life science companies with the digital marketing and AI capabilities they need to turn innovation into revenue.
I'm an independent digital marketing and AI strategy consultant with 25+ years of experience helping pharma, biotech, and life science organizations close the gap between scientific innovation and commercial success.
My career has been built at the intersection of science and commerce — leading global digital marketing strategy at companies like Vertex Pharmaceuticals and Biogen, and building the digital and technology capabilities that turn promising products into market leaders.
I founded Briidj Consulting LLC to bring that experience to organizations of all sizes as a trusted independent advisor who embeds alongside your commercial team. When you work with Briidj, you get me — not a team of juniors.
Too many breakthrough therapies underperform at launch — not because of the science, but because of gaps in digital capability, disconnected customer experiences, or the absence of AI-driven insight. Briidj exists to fix that.
A structured diagnostic of your current digital marketing maturity — channels, data infrastructure, content, and technology — benchmarked against best-in-class life sciences standards.
Identify where AI can create the most commercial value — from next-best-action engines and predictive analytics to GenAI content workflows and CRM intelligence.
Pre-launch through post-launch digital strategy for new products — ensuring your omnichannel presence is built before day one and optimized through year one and beyond.
End-to-end redesign of your customer engagement model — connecting digital, personal, and non-personal channels into a seamless, data-driven HCP and patient experience.
Turn fragmented data into commercial advantage. I help you define the data assets, analytics infrastructure, and insight workflows that drive smarter commercial decisions.
Upskill your commercial teams on digital and AI fundamentals so they can own, execute, and evolve capabilities beyond any single engagement.
Deep-dive into your current state — people, process, data, and technology — through stakeholder interviews and structured analysis.
Align on the future-state vision, capability priorities, and success metrics that matter most to your commercial goals.
Build a pragmatic roadmap with clear workstreams, owners, timelines, and investment guidance — no generic frameworks.
Drive implementation alongside your team, track progress, and iterate — staying accountable until outcomes are achieved.
Generative AI has moved from pilot to production. The pharma and biotech companies pulling ahead aren't just experimenting — they're embedding AI into the core of their commercial engine. Here's what separates the leaders from the laggards.
OmnichannelThe industry has been talking about omnichannel for a decade. Most companies still aren't doing it. Here's a clear-eyed look at what genuine omnichannel engagement requires.
Data StrategyYou can't build a 21st-century commercial organization on 20th-century data infrastructure. The good news: you don't have to overhaul everything at once.
Whether you're preparing for a launch, assessing your digital maturity, or trying to figure out where AI fits in your commercial strategy — I'd love to hear what you're working on.